Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Bruce L who wrote (3576)	1/10/2000 12:36:00 PM
From: Lucky888	Read Replies (1) \| Respond to of 4140

SNRS -- The game might be over before it even starts. L.

To: Bruce L who wrote (3576)	1/10/2000 4:24:00 PM
From: Wally Mastroly	Respond to of 4140

DIARY-U.S. FDA advisory meetings through Feb. 23: marketwatch.newsalert.com OPHTHALMIC DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE DATE: Jan. 13, 0930/1430 and Jan. 14, 0930/1430 LOCATION: Corporate Bldg., conference room 020B, 9200 Corporate Blvd., Rockville, MD. CONTACT: Sara Thornton, Centre for Devices and Radiological Health, FDA, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2053 On Jan. 13, the committee will discuss, make recommendations, and vote on a premarket approval application from Sunrise Technologies Inc. for a holmium laser for the correction of hyperopia using laser thermal keratomileusis. On Jan. 14, the committee will discuss and make recommendations on the reclassification of an artificial eye lubricating solution and the classification status for currently unclassified eyelid weight devices.